GLP-1 agonists, such as semaglutide and tirzepatide, mimic the natural GLP-1 (glucagon-like peptide-1) hormones your body produces
Safety and Risk Management Safety assessment Although animal experiments have shown that BPC 157 has good tolerance, its safety in humans has not been fully verified
Here's the real challenge, and we can't stress this enough: spinal discs have a terrible blood supply
the literature has not yet caught up to either
3a and Additional file 1: Table S7)
Apart from improvements in multiple cardiometabolic risk factors, tirzepatide also improves various obesity-related complications such as obstructive sleep apnoea (OSA), metabolic dysfunction-associated steatohepatitis (MASH) and heart failure with preserved ejection fraction [28,29,30]